Introduction Colonic self-expanding metallic stent(C-SEMS) is used to relieve malignant bowel obstruction. Our study aims to assess and review the outcomes of C-SEMS in patients with colorectal cancer against current guidance(1-2).
Method Retrospective review was conducted of all C-SEMS inserted between 2010 - 2015 and procedure-related outcomes and adherence to national guidelines was assessed.
Results 85 C-SEMS were inserted in 83 patients (32 female)– 72 were palliative decompression and 11 as bridge to surgery. Mean age was 74.1 years. 78 had left-sided colonic lesions, 3 right-sided colonic lesions and 2 low rectal lesions. All patients had CT scan prior to C-SEMS, one had radiological evidence of perforation and was stented with good outcome. Evolution Cook uncovered stents was used in all cases. Success 1 st attempt was achieved in 93%(n=79), of the 6 remaining patients - 2 had successful repeat attempt, 2 died from perforation,one patient had cardiopulmonary arrest mid-procedure (this patient had a pre-existing DNACPR in place), one was deemed too unwell for endoscopy and managed supportively. Patients with low rectal lesions tolerated C-SEMS well without troublesome tenesmus. Immediate complications occurred in 9.4%(n=8) - perforation and death(n=2),stent migration(n=6). Late complications in 16.4%(n=14) re-obstruction due to tumour growth, of which 2 died from perforation. 7 out of 8 patients who subsequently underwent surgery had a de-functioning stoma.11 patients had C-SEMS as bridge to surgery - 10 had successful surgery and one died from complications of anastomotic leak. We had no bleeding complications, including those 21 patients who were on anti-platelet/anti-coagulants. 30 day mortality rate was 4.8% (n=4). Overall mortality was 36.4%, all were palliative intent C-SEMS.
Conclusion C-SEMS is a safe and effective alternative to surgery in malignant colorectal obsturction as demonstrated in our review. Although current national guidelines suggest otherwise, our study shows C-SEMS is an alternative in right-sided and low rectal lesions in expert hands. In acute bowel obstruction, patients on anti-platelet/anti-coagulant should proceed with C-SEMS, as the risk of haemorrhage following C-SEMS is reportedly low (2).
. National Institute for Health and Clinical Excellence Colorectal cancer Clinical guideline [CG131], 2014.
. SVM Murugesan, M Hendrickse.Colonic stenting in patients on P2Y12 receptor antagonists and direct oral anticoagulants:are current BSG/ESGE guidelines practical?Gut2016. doi:10.1136/gutjnl-2016-311781.
Disclosure of Interest None Declared
- COLORECTAL CANCER
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.